ErbaLisa COVID-19: CE-marked Enzyme Immunoassay (ELISA) kits for the detection of IgG and IgM antibodies to SARS-CoV-2 in human serum.
Erba Mannheim has developed reliable and automation-friendly COVID-19 ELISA kits, allowing for comprehensive and accurate IgG and IgM antibody assessment. Our solid phase assays use proven technology, and total incubation time is 50 min at room temperature with a simple one step serum dilution. ErbaLisa COVID-19 assays are built for superior performance and reliable interpretation of results.
ErbaLisa COVID-19 IgG
CE-marked Enzyme Immunoassay (ELISA) kit for the detection of IgG antibodies to SARS-CoV-2 in human serum.
Main Features:
Number of tests: 96
Principle: Indirect ELISA using recombinant Spike subunit antigen
Tracer: HRP-Labelled Anti-human IgG
Assay format: Semi-quantitative
Reading wavelength: 450nm
Storage: 2-8ºC
Built for convenience:
Ready to use reagents
Removable strips
Break-apart wells
All incubation steps at room temperature
Interchangeable reagents
Calibrator and Controls included
Ready for automation
1:21 sample dilution can be performed directly on microwell plate
Performance characteristics:
58 serum samples collected from previously RT-PCR confirmed COVID-19 patients were tested. 107 Normal healthy patients with samples collected before COVID-19 outbreak (prior to December 2019) were tested. The results are as follows: